… Canadian Cardiovascular Society (CCS) released the original practice guidelines on the use
of antiplatelet therapy (APT) in the outpatient setting in … ) on the use of antiplatelet agents in …

… Canadian cardiologists from six provinces (Appendix S1), including those who had
participated in previous practice assessments with the Canadian Heart Research Centre (CHRC), …

… A substantial body of literature regarding the efficacy and safety of antithrombotic therapy in
… the association between BP control and CV outcomes have used a 24-hour ambulatory BP …

… use of antiplatelet therapy in acute coronary syndromes, as well as updates to the Canadian
and European Society of Cardiology … Cardiac Societies. 2017 ESC focused update on dual …

… Canadian Cardiovascular Society antiplatelet therapy guidelines recommend the use of …
as first-line platelet P2Y12 receptor antagonists for treatment of moderate- to high-risk acute …

… Antithrombotic prescriptions were defined as any antiplatelet or anticoagulant agent
prescribed by a community or hospital prescriber to a HD patient from the TGH HD outpatient unit. …

… , we used the 2016 Canadian Cardiovascular Society (CCS) … gastroprotective therapy
included the need of aspirin therapy … and use of multidisciplinary care in the outpatient setting, …

… The adherence to antithrombotic agents seen in our study is higher than that of a Canadian
study of 500 consecutive outpatients with VTE or NVAF, Citation28 which reported that 56.5…

… For persons aged 50 years or older without symptomatic CVD, we suggest low-dose aspirin
75 to 100 mg daily over no aspirin therapy (grade 2B). Canadian Cardiovascular Society (…

… Canadian Cardiovascular Society guideline recommendations, we observed an increased
use of dual pathway therapy … across all antithrombotic regimens. Our findings suggest that …